LivaNova (NASDAQ:LIVN) Shares Gap Down - Here's Why

Shares of LivaNova PLC (NASDAQ:LIVN - Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $37.51, but opened at $36.53. LivaNova shares last traded at $37.48, with a volume of 18,842 shares trading hands.

Wall Street Analyst Weigh In

LIVN has been the subject of several analyst reports. Stifel Nicolaus cut their price target on LivaNova from $72.00 to $60.00 and set a "buy" rating for the company in a research note on Wednesday, February 26th. Wolfe Research downgraded shares of LivaNova from an "outperform" rating to a "peer perform" rating in a research report on Wednesday, February 26th. Barclays lowered their target price on shares of LivaNova from $58.00 to $56.00 and set an "equal weight" rating on the stock in a report on Friday, March 7th. The Goldman Sachs Group cut their price target on shares of LivaNova from $64.00 to $55.00 and set a "buy" rating for the company in a report on Monday, March 3rd. Finally, Needham & Company LLC reaffirmed a "buy" rating and issued a $64.00 price objective on shares of LivaNova in a report on Monday, March 17th. Two investment analysts have rated the stock with a hold rating, five have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of $61.17.

LivaNova Trading Up 0.4 %

The company has a quick ratio of 2.87, a current ratio of 3.37 and a debt-to-equity ratio of 0.46. The business's fifty day moving average is $38.07 and its 200 day moving average is $45.75. The stock has a market cap of $2.01 billion, a PE ratio of 87.96 and a beta of 0.90.

Institutional Investors Weigh In On LivaNova

Institutional investors and hedge funds have recently modified their holdings of the company. UMB Bank n.a. boosted its position in LivaNova by 340.5% during the first quarter. UMB Bank n.a. now owns 837 shares of the company's stock worth $33,000 after purchasing an additional 647 shares in the last quarter. CWM LLC boosted its position in shares of LivaNova by 52.3% in the 1st quarter. CWM LLC now owns 871 shares of the company's stock worth $34,000 after buying an additional 299 shares in the last quarter. Russell Investments Group Ltd. increased its holdings in LivaNova by 17.1% during the 4th quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company's stock valued at $70,000 after acquiring an additional 219 shares in the last quarter. Sterling Capital Management LLC raised its position in LivaNova by 800.6% during the fourth quarter. Sterling Capital Management LLC now owns 1,621 shares of the company's stock worth $75,000 after acquiring an additional 1,441 shares during the last quarter. Finally, Central Pacific Bank Trust Division raised its position in LivaNova by 7.0% during the first quarter. Central Pacific Bank Trust Division now owns 4,407 shares of the company's stock worth $173,000 after acquiring an additional 290 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.